Vicriviroc maleate
Vicriviroc maleate is a potent piperazine-based CCR5 antagonist developed for HIV-1 treatment, demonstrating an IC50 of 0.91 nM. It has been investigated in clinical trials and is a valuable research tool for studying CCR5-mediated viral entry in both cellular and animal models of HIV infection.
Product Specifications
CAS Number
599179-03-0
Product Name Alternative
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
97.27% (May vary between batches)
Solubility
H2O:25 mg/mL (38.48 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.08 mM) ; DMSO:50 mg/mL (76.96 mM)
Smiles
OC (=O) \C=C/C (O) =O.COC[C@H] (N1CCN (C[C@@H]1C) C1 (C) CCN (CC1) C (=O) c1c (C) ncnc1C) c1ccc (cc1) C (F) (F) F
Molecular Formula
C32H42F3N5O6
Molecular Weight
649.7
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD63 (Late Endosomes Marker) (LAMP3/2881), CF594 conjugate, 0.1mg/mL
Recombinant Human Arginase-2/ARG2 Protein (His Tag)
Recombinant Human Arginase-2/ARG2 Protein (His Tag)
